Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Herman, S. E. M., Gordon, A. L., Hertlein, E., Ramanunni, A., Zhang, X., Jaglowski, S., Flynn, J., Jones, J., Blum, K. A., Buggy, J. J., Hamdy, A., Johnson, A. J., Byrd, J. C.Volume:
117
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2011-01-328484
Date:
June, 2011
File:
PDF, 570 KB
english, 2011